JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 14 No. 8 615-617
© 1973 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hisada, K.
Right arrow Articles by Ando, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hisada, K.
Right arrow Articles by Ando, A.

Radiolanthanides as Promising Tumor Scanning Agents

Kinichi Hisada and Atsushi Ando

School of Medicine and School of Paramedicine, Kanazawa University, Kanazawa, Japan

Correspondence: For reprints contact: Kinichi Hisada, Dept. of Nuclear Medicine, Kanazawa Univ. School of Medicine, 13-1 Takara-machi, Kanazawa-shi, Japan.

ABSTRACT

Based on the previous findings that some of the elements in the Group III and in the Period VI of the periodic table have a tumor affinity, the presence and extent of tumor affinity of radiolanthanides were examined using Yoshida sarcoma-bearing rats. Results indicated that all eight elements tested show some affinity for a tumor. Thulium-170 and 169Yb are nuclides that can favorably compare with that of 67Ga. Discovery of other good nuclides was discussed.

As a promising nuclide for clinical tumor scanning, 167Tm, 169Yb, and 175Yb (citrate form is preferable) were suggested.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1973 by the Society of Nuclear Medicine.